Class of Stock [Axis]
Common Stock, par value $0.0001 per share
Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $230.00 per whole share
Series A Preferred Stock [Member]
Debt Instrument [Axis]
Convertible Notes Payable [Member]
Product and Service [Axis]
Sale [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Common Stock Subscribed [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Asset Acquisition [Axis]
NexGenAI [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
Six Customers [Member]
Advertising Campaigns [Member]
Three Customers [Member]
Webinar Services [Member]
Antidilutive Securities [Axis]
Warrants [Member]
Stock Options [Member]
CD38 Assets [Member]
Counterparty Name [Axis]
Vy Gen [Member]
Transaction Type [Axis]
Co Development Rights [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Co Development Options [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
License Agreement [Member]
Related and Nonrelated Parties [Axis]
Purple Bio Tech [Member]
Long-Term Debt, Type [Axis]
Oct 2022 Convertible Promissory Note [Member]
Dec 2023 Convertible Promissory Note [Member]
Related Party [Member]
Short-Term Debt, Type [Axis]
April 2024 Unsecured Note [Member]
YA Note-1 [Member]
Yorkville Convertible Note [Member]
Derivative Instrument [Axis]
Standby Equity Purchase Agreement [Member]
Y A Note 2 [Member]
Derivative Liability [Member]
Measurement Input Type [Axis]
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Conversion Price [Member]
Measurement Input, Share Price [Member]
Eidl Loan [Member]
Award Type [Axis]
Public Warrants [Member]
Sale of Stock [Axis]
Private Placement Warrants [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Inputs, Level 1 [Member]
Measurement Input, Exercise Price [Member]
Warrant Liabilities [Member]
Public Offering [Member]
Pre Funded Warrants [Member]
Series A Warrants [Member]
Series B Warrants [Member]
Series Warrants [Member]
Warrant Note Subscription Receivables [Member]
Private Placement [Member]
Legal Entity [Axis]
SNAP Biosciences Inc [Member]
Two Investor [Member]
Consulting Agreement [Member]
Colleen Delaney [Member]
Plan Name [Axis]
Modification Of Options [Member]
Coral Investment Partners [Member]
Common Class A [Member]
Common Class B [Member]
Financial Instrument [Axis]
Subscription Receivable Sept 2023 [Member]
Subscription Receivable Sept 2023 One [Member]
December 2023 Financing [Member]
February 2024 Financing [Member]
Yorkville [Member]
Stock Issued For Services [Member]
Convertible Note [Member]
Warrant Holder 1 Exercise Price 59. 40 [Member]
Warrant Holder 1 Exercise Price 118. 80 [Member]
Warrant Holder 1 Exercise Price 296. 80 [Member]
Warrant Holder 2 Exercise Price 59. 40 [Member]
Warrant Holder 2 Exercise Price 296. 80 [Member]
Warrant Holder 5 Exercise Price 59. 40 [Member]
Warrant Holder 18 Exercise Price 178. 20 [Member]
Warrant Holder 20 Exercise Price 50. 00 [Member]
Warrant Holder 21 Exercise Price 38. 00 [Member]
Series Warrants A And B Exercise Price 27. 20 [Member]
Series A Warrants Exercise Price 27. 20 [Member]
Series B Warrants Exercise Price 27. 20 [Member]
Warrant Holder 22 Exercise Price 25. 00 [Member]
Warrant Holder 22 Exercise Price 28. 00 [Member]
Warrant Holder 23 Exercise Price 25. 00 [Member]
Warrant Holder 23 Exercise Price 28. 00 [Member]
Warrant Holder 24 Exercise Price 28. 00 [Member]
Pre Funded Warrants 2 Exercise Price 0. 002 [Member]
Pre Funded Warrants 3 Exercise Price 0. 002 [Member]
Warrant Holder 25 Exercise Price 12. 00 [Member]
Gear Therapeutics [Member]
Two Privately Held Companies [Member]
Nex Gen A I Affiliates Network Platform [Member]
Five Privately Held Companies [Member]
Three Privately Held Companies [Member]
Privately Held Company [Member]
Long-Lived Tangible Asset [Axis]
First Year Extension [Member]
Second Year Extension [Member]
Mehalick [Member]
Yerace [Member]
Car T License [Member]
Finders Fee And Indemnity Agreement [Member]
Master Services Agreements [Member]
Gear Cell Therapy Platform [Member]
AG Bio Life Capital I LP [Member]
Board Of Directors [Member]
Nex Gen A I Solutions Group Inc [Member]
Segments [Axis]
Biotechnology Segment [Member]
Technology Segment [Member]
Biotechnology Segment [Member]
Technology Segment [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Award Timing MNPI Disclosure [Text Block]
Award Timing MNPI Considered [Flag]
Auditor Firm ID
Auditor Name
Auditor Location
ASSETS
CURRENT ASSETS
Cash
Marketable securities
Interest receivable
Prepaid assets
TOTAL CURRENT ASSETS
PROPERTY AND EQUIPMENT
Furniture and fixtures, net
OTHER ASSETS
Investments
Intangible assets, net
Co-development rights, net
Right of use asset, net of accumulated amortization
Total other assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable
Accrued expenses
Convertible notes payable, net of debt discount of $0 and $435,635
Convertible notes payable, in default
Right of use liability, current portion
Customer deposit
Derivative liability
Other current liabilities
TOTAL CURRENT LIABILITIES
LONG TERM LIABILITIES
SBA loan payable
Derivative liability warrants
Right of use liability, non-current portion
TOTAL LONG TERM LIABILITIES
TOTAL LIABILITIES
COMMITMENTS AND CONTINGENCIES (NOTE 10)
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 10,000 designated as Series A, 0 and 6,520 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively
Common stock, $0.0001 par value, 150,000,000 shares authorized, 5,746,948 and 2,116,191 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively
Additional paid-in capital
Common stock subscribed
Subscription receivable
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY - CONTROLLING INTERESTS
TOTAL STOCKHOLDERS' EQUITY - NONCONTROLLING INTERESTS
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Debt Instrument, Unamortized Discount
Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Shares Authorized
Preferred Stock, Shares Outstanding
Preferred Stock, Shares Issued
Common Stock, Par or Stated Value Per Share
Common Stock, Shares Authorized
Common Stock, Shares, Outstanding
Common Stock, Shares, Issued
SALES
Total sales
Cost of goods
Gross profit
COST OF OPERATIONS
Research and development expense
Salary expense
Amortization expense
Professional services expense
Stock based compensation expense
General and administrative expenses
Selling and marketing expense
Total cost of operations
LOSS FROM OPERATIONS
OTHER INCOME (EXPENSE)
Interest expense
Interest income
Amortization of debt discount
Gain on forfeiture of customer deposit
Other income (expense), net
Unrealized gain on marketable securities
Unrealized loss on investments
Loss on write down of assets
Gain (loss) on extinguishment of debt
Change in fair value of derivative liabilities
TOTAL OTHER INCOME (EXPENSE), net
LOSS BEFORE INCOME TAXES
PROVISION FOR INCOME TAXES (BENEFIT)
NET LOSS
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
LOSS PER SHARE
Loss per share, basic
Loss per share, fully diluted
Weighted average number of common shares outstanding, basic
Weighted average number of common shares outstanding, diluted
Beginning balance, value
Beginning balance, shares
Shares issued for cash
Shares issued for cash, shares
Shares issued for SEPA
Shares issued for SEPA, shares
Shares issued for services
Shares issued for services, shares
Shares issued for investment
Shares issued for investment, shares
Asset purchase agreement
Asset purchase agreement, shares
Warrants issued for cash
Warrants issued for services
Pre-funded warrants exercise
Pre-funded warrants exercise, shares
Warrants issued in exchange for subscriptions receivable
Shares issued for the conversion of debt
Shares issued for the conversion of debt, shares
Preferred stock offering
Preferred share offering, shares
Preferred share conversion
Preferred share conversion, shares
Investments in private companies
Common stock issued for intangible asset purchase
Stock based compensation
Stock split adjustment
Stock split adjustment, shares
Net loss
Conversion of Stock, Shares Converted
Debt converted to equity
Debt converted to equity, shares
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization
Right of use asset amortization
Amortization of debt discount
Non-cash revenue
Stock based compensation
Shares issued for non-employee services
Warrants issued for services
Change in fair value of derivative liability
Change in fair value of derivative liability warrants
Loss on shares issued for conversion of debt
(Gain) loss on extinguishment of debt
Forgiveness of interest
Unrealized loss on investments
Unrealized gain on marketable securities
(Increase) decrease in:
Interest receivable
Prepaid assets
Increase (decrease) in:
Accounts payable
Accrued expenses
Right of use liability
Other current liabilities
NET CASH USED IN OPERATING ACTIVITIES
INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES
FINANCING ACTIVITIES
Proceeds from notes payable
Repayment of notes payable
Shares issued for SEPA
Shares issued for cash
Warrants issued for cash
Pre-funded warrants exercise
Preferred stock offering
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET INCREASE (DECREASE) IN CASH
CASH AT BEGINNING OF PERIOD
CASH AT END OF PERIOD
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest paid
Taxes paid
SUPPLEMENTAL NON-CASH DISCLOSURES
Subscriptions receivable
Shares issued for the conversion of debt
Shares issued for investment
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
CO-DEVELOPMENT OPTIONS
Debt Disclosure [Abstract]
CONVERTIBLE NOTES
Sba Loan Payable
SBA LOAN PAYABLE
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITY WARRANTS
Equity [Abstract]
CAPITAL STRUCTURE
Noncontrolling Interest [Abstract]
NON-CONTROLLING INTEREST
Investments, All Other Investments [Abstract]
INVESTMENTS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Retirement Benefits [Abstract]
401(k) PROFIT-SHARING PLAN
Income Tax Disclosure [Abstract]
INCOME TAXES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS
Segment Reporting [Abstract]
SEGMENT REPORTING
Pending Merger Transaction
PENDING MERGER TRANSACTION
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Cash
Property and Equipment
Intangible Assets
Investments and Marketable Securities
Leases
Research and Development
Impairment of Long-Lived Assets
Derivative Liability Warrants
Convertible Debt
Income Taxes
Use of Estimates
Reclassification
Employee and Non-Employee Share-Based Compensation
Recent Accounting Pronouncements
Revenue Recognition
Earnings Per Share
Going Concern
Fair Value of Financial Instruments and Measurements
Schedule of antidilutive shares
Schedule of derivative liability
Schedule of assumptions used for valuation
Schedule of changes in fair value of derivative liability
Schedule of fair value hierarchy
Schedule of fair value assumptions
Schedule of changes in fair value of warrant liabilities
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of weighted average assumptions
Schedule of warrants outstanding
Schedule of lease information
Schedule of future minimum rental payments
Schedule of effective income tax reconciliation
Schedule of income tax provision
Schedule of net operating loss carryforwards
Schedule of segment information
Reverse stock split
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares
Accumulated deficit
Net loss
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Cash uninsured amount
Depreciation expense
Intangible assets acquired
Research and development expenses
Asset impairment charges
Uncertain tax positions
Concentration risk percentage
Revenues
Customer deposits
Business Combination, Intangible Asset, Acquired, Finite-Lived [Table]
Intangible Asset, Acquired, Finite-Lived [Line Items]
Payments to Acquire Productive Assets
Other Notes Payable, Noncurrent
Repayments of Long-Term Debt
Capitalized Contract Cost, Gross
License fees
Capitalized Contract Cost, Accumulated Amortization
Capitalized Contract Cost, Net
Amortization
Offsetting Assets [Table]
Offsetting Assets [Line Items]
Fair value of derivative liability
Business Combination [Table]
Business Combination [Line Items]
Derivative assumption valuation
Fair value of derivative liability, beginning balance
Change in fair value
Extinguishment of fair value of liability
Fair value of derivative liability, ending balance
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Debt face amount
Interest rate
Convertible notes outstanding
Repayment of convertible debt
Debt in default
Debt converted, amount converted
Interest rate
Debt maturity date
Short-term debt
Convertible promissory note
Short-term debt replaced
[custom:DebtConversionConvertedInterestAmount1]
Debt Conversion, Converted Instrument, Shares Issued
Debt Instrument, Convertible, Conversion Price
Fair value derivative liability
Change in fair value of derivative liability
Transfers in or out of Level 3
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Proceeds from loans
Accrued interest rate
Notes payable
Derivative Instruments, Gain (Loss) [Table]
Derivative Instruments, Gain (Loss) [Line Items]
Financial liabilities fair value disclosure
Derivatives, determination of fair value
Fair value of liabilities, beginning
Change in valuation inputs
Fair value of liabilities, ending
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding
Options outstanding, beginning
Weighted average exercise price, beginning balance outstanding
Weighted average contractual life (years), options outstanding
Options granted
Weighted average exercise price, granted
Weighted average contractual life (years), granted
Options forfeited/expired
Weighted average exercise price, forfeited/expired
Options exercised
Weighted average exercise price, exercised
Options outstanding, ending
Weighted average exercise price, ending balance outstanding
Intrinsic value, options outstanding
Expected term, in years
Expected volatility
Risk-free interest rate
Dividend yield
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Date Issued
Warrants exercise price
Expiration
Total warrants outstanding
Common stock, par value
Preferred stock authorized
Preferred stock, par value
Common stock, shares outstanding
Number of shares issued
Conversion of stock, shares converted
Exercise price of warrants
Stock converted, shares issued
Aggregate exercise price of warrant
Proceeds from common stock
Investors description
Gross proceeds
Principal amount
Debt instrument stated percentage
Maturity period
Treasury stock
Preferred stock, shares issued
Preferred stock, shares outstanding
Proceeds from sale of preferred stock
Subscription receivable
Stock compensation expense
Unamortized stock-based compensation
Number of shares forfeited
Number of shares exercised
Number of shares expired
Warrants issued
Stock issued for debt, shares
Stock issued for debt, value
Proceeds from issuance of preferred stock
Subscription receivable
Proceeds subscriptions receivable
Subscriptions receivable net
Payment of commitment fee
Noncontrolling Interest [Table]
Noncontrolling Interest [Line Items]
Noncontrolling interest
Net of accumulated losses
Equity attributable to non-controlling interests
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
[custom:SubscriptionReceivable-0]
Investment Owned, Balance, Shares
Loss on investment
[custom:StockIssuedDuringPeriodSharesIssuedForInvestment]
[custom:StockIssuedDuringPeriodValueIssuedForInvestment]
Investment company fee paid shares indirectly
Investment company fee paid indirectly
Operating lease right of use asset, gross
Operating lease right of use asset, accumulated depreciation
Operating lease right of use asset
Operating lease liability
Operating lease liability, current
Operating lease liability, noncurrent
2026
Total minimum lease payments:
Less amount representing interest
Present value of minimum lease payments:
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Monthly rent
Operating lease expense
Annual salary
Initial license fee
Annual maintenance fee description
Contractual obligation
Agreement amendment fee
Payment for fees
Customer deposit receivable
Employer contributions
Income tax benefit at statutory rate
Change in valuation allowance
Expected federal statutory income tax provision/rate
[custom:ExpectedEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate]
State income taxes, net of federal benefit
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
Other
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Income tax benefit at statutory rate
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Change in valuation allowance
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective income tax rate reconciliation
Effective Income Tax Rate Reconciliation, Percent
Deferred tax assets
Net operating loss carryforwards
Section 174 R&D
PPE and intangible assets
State taxes
Subtotal
Valuation Allowance
Net deferred tax assets (liabilities)
Net operating loss carry forwards
DisclosureTable [Table]
DisclosureLineElements [Line Items]
Shares issued
Note receivable
Investment
Accrued professional fees
Other investments
Intangible Asset, Finite-Lived [Table]
Finite-Lived Intangible Assets [Line Items]
Stock issued for purchase of assets, shares
Stock issued for purchase of assets, value
Intangible Assets, Net (Excluding Goodwill)
Amortization of intangible assets
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Sales
Cost of goods sold
Total operating expenses
Net (loss) gain from operations
Number of reportable segments
Total assets
Biotechnology Segment [Member] [Default Label]
Technology Segment [Member] [Default Label]
Assets, Current
Property, Plant and Equipment, Net
Other Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Interest Expense, Nonoperating
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Other Noncash Income
Employee Benefit and Share-Based Payment Arrangement, Noncash
WarrantsIssuedForServices
Gain (Loss) on Extinguishment of Debt
Increase (Decrease) in Interest and Dividends Receivable
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Other Accounts Payable
Increase (Decrease) in Accrued Liabilities
Increase (Decrease) in Other Current Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
SharesIssuedForSepa
Proceeds from Issuance of Warrants
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
SharesIssuedForConversionOfDebt
SharesIssuedForInvestment
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Cash and Cash Equivalents, Policy [Policy Text Block]
Extinguishment of Debt, Gain (Loss), Net of Tax
Liabilities, Fair Value Disclosure
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable
OperatingLeaseRightOfUseAssetAccumulatedDepreciation
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ExpectedIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Deferred Tax Assets, State Taxes
Deferred Tax Assets, Valuation Allowance